Professional Documents
Culture Documents
Anie201610462 Sup 0001 Misc Information1
Anie201610462 Sup 0001 Misc Information1
anie_201610462_sm_miscellaneous_information.pdf
Supplementary Information
Table of Contents:
1. General 3
2. Preparation of ligands 4
3. Procedures for asymmetric Grignard synthesis of tertiary alcohols,
including ligand recovery 8
4. Tertiary Alcohol Products from Asymmetric Grignard Synthesis 11
5. Asymmetric synthesis of α-tocopherol precursor 23
6. Comparison of methods for asymmetric nucleophilic addition to ketones 24
7. Mechanistic considerations 27
8. References 30
List of Abbreviations
2
1. General
All chemicals were supplied by Aldrich apart from natural phytol, which was supplied by
Wuhan ChemFaces Biochemical Co. and both enantiomers of cyclohexane-1,2-diamine-
tartrate provided by Arran Chemical Company, Athlone, Ireland. (7R,11R)-1-(2,5-
Dimethoxy-3,4,6-trimethylphenyl)-7,11,15-trimethylhexadecan-3-one (the ketone precursor
of α-tocopherol precursor A (Scheme 2 in main text) was prepared in seven steps from
natural phytol.1 Diethyl ether, toluene and THF were dried prior using a Grubbs type
solvent system (Innovative Technologies, Model: PS-400-3-MD), other solvents and
reagents were used without further purification. Water content of dried solvents was
determined before use by Karl Fisher titration, on Aquamax v2.6i KF coulometric system.
All reactions that required air/moisture free conditions were carried out under nitrogen
using standard Schlenk manifold techniques. Microwave assisted reactions were
performed using CEM Discover microwave instrument (S-series).
All NMR analysis was performed using 300, 400 or 500 MHz Varian spectrometers. NMR
samples were made up in CDCl3. 1H and 13C NMR chemical shifts are relative to TMS.
HPLC analysis was performed using Agilent Technologies 1260 Infinity system with auto-
sampler, combined with Agilent UV-vis detector. Chiral columns Chiralpak® IA, IB, IC, and
Chiracel® OJH of an internal diameter 4.6 mm, 250 mm length, particle size of 5 µm,
coupled to a guard column of internal diameter of 4.6 mm and length of 50 mm were used
to separate enantiomers. Columns were mounted in an Agilent column switcher device.
HPLC was performed in normal phase, with heptane and ethanol as solvents. Both
solvents were filtered through an acrodisc CR 13 syringe filter with 0.2 µm PTFE before
injection on the column.
Supercritical Fluid Chromatography (SFC) was performed using ACQUITY UPC2 system
with auto-sampler, combined with PDA Detector Type UPLC eLambda 800 nm. Chiral
column Chiralpak® IA-3 of internal diameter of 4.6 mm, 100 mmL with particles size of 3
µm was used to separate diastereoisomers in a single case with methanol as a co-solvent.
HLPC and SFC samples were prepared by diluting crude mixture with heptane in 1 mL
sample vial to approximately 1 mg/mL.
Flash chromatography was performed using silica 60, 40-63 µm of diameter, supplied by
Apollo Scientific. TLC was done with pre-coated silica 60 plates F-254. Realisation of
plates was done under UV light or developed by iodine vapour.
3
2. Preparation of Ligands
Resolution of (±)-trans-1,2-diaminocyclohexane
All mother liquors combined (approximately 1.5 L) were treated with conc. HCl (50 mL,
~650 mmol) and heated to reflux. Acetone (2.5 L) was added in portions (250 mL) over 1 h
under reflux, which was continued overnight. Mixture was cooled to room temperature.
The white precipitate was filtered, washed with acetone (3 x 100 mL), dried under high
vacuum. Product - (S,S)-1,2-diaminocyclohexane hydrochloride was recrystallized from
minimum amount of hot water to yield colourless, crystalline powder (45.6 g, 137.25 mmol,
28% yield, >99.8% ee [HPLC]).
HPLC conditions: Column: IA, Mobile phase: heptane : ethanol (97:3), enantiomers at
19.11 min (R) and 21.72 min (S). Flow rate: 1 ml / min.
1
H NMR (300 MHz, CDCl3): δ 4.12 (s, 2H), 3.22-3.13 (m, 2H), 2.05-1.93 (m, 2H), 1.74-1.27
(m, 2H), 1.42-1.28 (m, 2H), 1.26-1.10 (m, 2H) ppm.
4
Release of free (1R,2R)-cyclohexane-1,2-diamine
Free amine was released using a modification of the literature procedure.3 (1R,2R)-
Cyclohexane-1,2-diamine-tartrate (30.2 g, 114 mmol, 1 eq.) was suspended in DCM (250
mL) and NaOH (11 g, 276 mol, 4.8 eq.), dissolved in water : saturated brine mixture (152
mL, 1:1 ratio) was added slowly. The mixture was left to stir at room temperature for 1h
under a stream of nitrogen. The organic layer was separated and the aqueous layer was
washed with DCM (100 mL x 4). The combined organic layers were dried using anhydrous
Na2SO4 and the solvent was evaporated by rotary evaporator to yield (1R,2R)-
cyclohexane-1,2-diamine as crystalline, white solid (8.4 g, 65% yield). NMR shifts match
those in the literature.4
1
H NMR (300MHz, CDCl3): δ 2.32-2.21 (m, 2H), 1.89-1.78 (m, 2H), 1.72-1.64 (m, 2H), 1.43
13
(s, 4H), 1.36-1.21 (m, 2H), 1.21-1.01 (m, 2H); C NMR (101 MHz, CDCl3): δ 74.6, 33.1,
24.5.
diethyl ether (3 x 100 mL). The remaining solids were then treated with 2M NaOH (250
mL) and the free diamine was extracted with DCM (2 x 150 mL). The organic extracts were
combined, washed with DIW (2 x 100 mL), brine (100 mL) and dried over anhydrous
Na2SO4. The solvent was removed to yield a white solid. (11.25 g, 71% yield).
1
H NMR (300MHz, CDCl3): δ 4.56 (s, 1H), 3.13 (s, 1H), 2.29 (broad, 1H), 2.06-1.94 (m,
13
2H), 1.67-1.53 (m, 2H), 1.43 (s, 9H), 1.15-1.07 (m, 4H), 1.07-0.98 (m, 2H); C NMR (101
MHz, CDCl3,): δ 156.3, 79.2, 57.8, 55.9, 35.4, 33.2, 28.6, 25.4, 25.3. (Values consistent
with the literature data.5)
6
(80:20) as an eluent and recrystallized from hot IPA/water (2:1) to yield a purified ligand
1a-1b.
2,4-di-tert-butyl-6-((((1R,2R)-2-(dimethylamino)cyclohexyl)(methyl)
amino)methyl)phenol (1a)
2-((((1R,2R)-2-(dimethylamino)cyclohexyl)(methyl)amino)methyl)-6-
(trifluoromethyl)phenol (1b)
7
3. Procedures for asymmetric Grignard synthesis of tertiary alcohols, including
ligand recovery.
Ligand (0.1 mmol, 1.0 eq.) was added to a flame dried 15 ml Schlenk flask, followed by
addition of dry toluene (0.5 mL) and solution of ketone in toluene (0.25 mL of 0.4 M, 0.1
mmol, 1.0 eq.). The mixture was agitated at r.t. for 5 min then cooled to -78 ˚C in acetone /
dry ice bath. Grignard reagent in toluene/ether (6:1), (0.42 M, 0.5 ml, 0.21 mmol, 2.1 eq.)
was added slowly dropwise. The mixture was agitated at -78 ˚C and monitored by HPLC
until no more product formation was detected. The reaction was quenched with IPA/water
(3:1, 2 mL), followed by sat. NH4Cl (2 mL) and heptane (2 mL) and mixture was allowed to
warm to r.t. The aqueous layer was separated, washed with heptane (3 x 5 mL). The
organic phases were combined. Ligand was recovered using procedure A. The organic
fractions were combined washed with water (3 x 5mL), brine (5 mL) and then dried over
anhydrous MgSO4. The solvent was removed by rotary evaporator. The crude product was
purified by flash chromatography using diethyl ether : cyclohexane mixture as eluent.8
To the organic crude reaction mixture (1 mL, 0.1 mmol scale) a few drops of acetic acid
(glacial) was added. The mixture was passed through a 2-3 cm silica column in a glass
Pasteur pipette (Figure 1), followed by 5 mL of cyclohexane : ethyl acetate (50:50). The
organic fractions were combined and the solvent was evaporated to yield a crude product.
The ligand was recovered from the silica column by elution with cyclohexane : ethyl
acetate : triethylamine (50:40:10) wash. The solvent was removed by rotary evaporator to
yield a crude ligand, which was further purified by recrystallization from hot water : IPA
(1:1) to yield 75% - 85% of pure, recovered ligand which can be reused in subsequent
reactions.
8
Figure 1. Rapid set-up for removal & recovery of ligand from the crude reaction mixture
Ligand L1 (3.14 g, 8.32 mmol, 1.0 eq.) was dissolved in 30 mL of dry toluene in a
previously flamed dried 250 mL Schlenk flask. Acetophenone (20.8 mL of 0.4 M solution in
dry toluene, 8.32 mmol, 1.0 eq.) was added and the mixture was cooled to -78 ˚C in
acetone/dry ice bath. Ethylmagnesium bromide in toluene/ether (4:1), (0.75 M, 23.3 ml,
17.47 mmol, 2.1 eq.) was added slowly dropwise. The mixture was agitated at -78 ˚C and
monitored by HPLC until no more product formation was detected. The reaction was
quenched with IPA/water (3:1, 50 mL), followed by sat. NH4Cl (50 mL) and heptane (50
mL) and mixture was allowed to warm to r.t. The aqueous layer was separated, washed
with heptane (3 x 50 mL). Organic phases were combined. The ligand was recovered
using Recovery Procedure B. Organic phases were washed with water (3 x 150 mL), brine
(150 mL), dried over anhydrous MgSO4. The solvent was removed by rotary evaporator.
The crude product was purified by flash chromatography using diethyl ether : cyclohexane
mixture as eluent to yield (S)-2-phenylbutan-2-ol (937 mg, 75% yield, 78% ee).
9
Standard ligand recovery procedure (B). The organic crude reaction mixture (8.32 mmol
scale) was washed with aq. acetic acid (10%, 4 x 250 mL) until the ligand was no longer
visible on TLC. Washes were combined, neutralized with aq. NaHCO3 (sat.) and the ligand
was extracted with toluene (3 x 250 mL). The combined organic phases were washed with
water (2 x 250 mL), brine (250 mL) and dried over anhydrous sodium sulfate. Solvent was
removed by rotary evaporator to yield a crude ligand, which was further purified by
recrystallization from hot water : IPA (1:1) to yield 75% - 85% of pure, recovered ligand
which can be reused in subsequent reactions.
10
4. Tertiary Alcohol Products from Asymmetric Grignard Synthesis
(S) -‐ Table 2, Entry 1 (R) -‐ Table 2, Entry 2
11
(R)
-‐
Table
2,
Entry
6
2-(4-methoxyphenyl)butan-2-ol
Colourless oil (53% yield); 1H NMR (300 MHz, CDCl3) δ 7.33 (d, J = 9.0
Hz, 2H), 6.85 (d, J = 9.0 Hz, 2H), 3.80 (s, 3H), 1.72-1.91 (m, 2H), 1.53
(s, 3H), 0.78 (apparent t, J = 7.4 Hz, 3H); 13C NMR (101 MHz, CDCl3): δ
157.9, 139.7, 125.9, 113.2, 74.5, 55.2, 36.7, 29.5, 8.5. HPLC
conditions: Column: IB, Mobile phase: heptane : ethanol (97:3), enantiomers at 19.24 min
and 20.27 min. Flow rate: 1 ml / min. NMR shifts are consistent with the literature.9
12
2-(4-methoxyphenyl)-3-methylbutan-2-ol
Colourless oil (60% yield); 1H NMR (400 MHz, CDCl3) δ 7.34 (m, 2H),
HO
6.86 (m, 2H), 3.79 (s, 3H), 1.99 (m, 1H), 1.68 (s, 1H), 1.50 (s, 3H),
13
0.85 (d, J = 6.9 Hz, 3H), 0.82 (d, J = 6.9 Hz, 3H); C NMR (101 MHz,
O
CDCl3): δ 157.9, 139.8, 126.4, 113.1, 76.5, 55.2, 38.7, 26.4, 17.4, 17.2.
HPLC conditions: Column: IB, Mobile phase: heptane : ethanol (97:3), enantiomers at 6.71
min and 7.12 min. Flow rate: 1 ml / min. NMR shifts are consistent with the literature.10
2-(4-(trifluoromethyl)phenyl)butan-2-ol
13
2-(o-tolyl)butan-2-ol
Colourless liquid (71% yield); 1H NMR (300 MHz, CDCl3): δ 7.52-7.43 (m,
1H), 7.53-7.32 (m, 3H), 2.61 (s, 3H), 2.03-1.94 (m, 2H), 1.71 (s, 3H), 0.90
13
(apparent t, J = 7.4 Hz, 3H); C NMR (101 MHz, CDCl3): δ 144.6, 135.4,
132.4, 126.7, 126.7, 125.3, 76.0, 34.4, 28.7, 22.2, 8.4; HPLC conditions:
Column: IA, Mobile phase: heptane : ethanol (98:2), enantiomers at 7.62 min and 9.60
min. Flow rate: 1 ml / min. NMR shifts are consistent with the literature.12
14
5-ethyl-6,7,8,9-tetrahydro-5H-benzo[7]annulen-5-ol
White solid (73% yield); 1H NMR (400 MHz, CDCl3): δ 7.42-7.33 (m, 1H),
7.33-7.05 (m, 3H), 3.09-2.72 (m, 2H), 2.44-2.02 (m, 2H), 1.95-1.90 (m, 2H),
13
1.90-1.86 (m, 4H), 0.97 (apparent t, J = 7.5 Hz, 3H); C NMR (101 MHz,
CDCl3): δ 143.2, 128.2, 126.6, 124.9, 122.8, 118.8, 84.1, 39.4, 37.6, 33.0, 29.5, 20.8, 8.6;
HPLC conditions: Column: OJH, Mobile phase: heptane : ethanol (96:04), enantiomers at
10.22 min and 11.12 min. Flow rate: 1 ml / min. NMR shifts are consistent with the
literature.13
1-ethyl-1,2,3,4-tetrahydronaphthalen-1-ol
White solid (57% yield); 1H NMR (400 MHz, CDCl3): δ 7.64-7.46 (m, 1H),
7.44-7.02 (m, 3H), 2.92-2.69 (m, 2H), 2.59-2.46 (m, 2H), 2.17-2.01 (m, 2H),
13
2.01-1.77 (m, 2H), 0.95 (apparent t, J = 7.5 Hz, 3H); C NMR (101 MHz,
CDCl3): δ 142.2, 136.9, 128.9, 127.0, 126.3, 126.2, 72.7, 35.3, 34.9, 29.9, 19.7, 8.6; HPLC
conditions: Column: IA, Mobile phase: heptane : ethanol (99:1), enantiomers at 19.80 min
and 24.69 min. Flow rate: 1 ml / min. NMR shifts are consistent with the literature.14
15
(S)-1-ethyl-2,3-dihydro-1H-inden-1-ol
Colourless needles (52% yield); 1H NMR (300 MHz, CDCl3): δ 7.44 – 7.32
(m, 1H), 7.32 – 7.19 (m, 3H), 3.16 – 2.74 (m, 2H), 2.42 – 2.06 (m, 2H),
13
2.06 – 1.69 (m, 2H), 0.98 (apparent t, J = 7.4 Hz, 3H); C NMR (101MHz,
CDCl3): 147.4, 143.2, 128.4, 126.7, 125.0, 122.9, 84.2, 39.5, 33.1, 29.5, 8.7; ;
[α]D20
=
−3.5
(c=1.0
in
CHCl3)
for
(S)
enantiomer; HPLC conditions: Column: IA, Mobile phase:
heptane : ethanol (99:1), enantiomers at 12.02 min and 12.85 min. Flow rate: 1 ml / min.
NMR shifts and optical rotations are consistent with the literature.14
16
4-ethylchroman-4-ol
Colorless solid (45% yield); 1H NMR (300 MHz, CDCl3): δ 7.60-7.33 (m,
1H), 7.27-7.08 (m, 1H), 7.02-6.74 (m, 2H), 4.33-4.16 (m, 2H), 2.28-1.80 (m,
13
4H), 0.92 (apparent t, J = 7.5 Hz, 3H); C NMR (75 MHz, CDCl3): δ 154.5,
129.0, 127.5, 126.4, 120.7, 117.2, 68.7, 63.0, 34.0, 34.0, 8.5; HPLC
conditions: Column: OJH, Mobile phase: heptane : ethanol (97:03), enantiomers at 14.62
min and 23.26 min. Flow rate: 1 ml / min; HRMS (m/z): [M]+: calcd. for C11H14O2: 178.0994;
found: 178.0992.
1-methyl-2,3-dihydro-1H-inden-1-ol
White solid (86% yield); 1H NMR (400 MHz, CDCl3) δ 7.42-7.31 (m, 1H), 7.30-
13
7.27 (m, 3H), 3.11-2.75 (m, 2H), 2.31-2.07 (m, 2H), 1.59 (s, 3H); C NMR
(101 MHz, CDCl3): δ 148.3, 142.7, 128.2, 126.8, 125.0, 122.2, 81.2, 42.3,
29.4, 27.3; HPLC conditions: Column: IB, Mobile phase: heptane : ethanol (96:4),
enantiomers at 6.11 min and 6.38 min. Flow rate: 1 ml / min. NMR shifts are consistent
with the literature.14
17
1-isobutyl-2,3-dihydro-1H-inden-1-ol
Colourless solid (49% yield) ; 1H NMR (400 MHz, CDCl3): δ 7.42-32 (m,
1H), 7.32-7.08 (m, 3H), 3.14-2.72 (m, 2H), 2.42-2.03 (m, 2H), 1.97-1.81
13
(m, 2H), 1.76-1.61 (m, 1H), 1.08-0.83 (m, 6H); C NMR (101 MHz,
CDCl3): δ 148.3, 142.8, 128.1, 126.6, 124.9, 122.8, 84.1, 48.6, 40.4, 29.6, 24.9, 24.8, 24.4;
HRMS (m/z): [M]+: calcd. for C13H18O: 191.1435; found: 191.1470; HPLC conditions:
Column: IA, Mobile phase: heptane : ethanol (96:4), enantiomers at 9.19 min and 11.08
min. Flow rate: 1 ml / min.
18
1-cyclopentyl-2,3-dihydro-1H-inden-1-ol
White solid (80% yield); 1H NMR (400 MHz, CDCl3): δ 7.40–7.28 (m, 1H),
7.28–7.13 (m,3 H), 3.05–2.76 (m, 2H), 2.48–2.01 (m, 4H), 1.87–1.74 (m,
13
1H), 1.71–1.47 (m, 5H), 1.36–1.26 (m, 1H); C NMR (101 MHz, CDCl3):
δ 147.4, 143.3, 128.1, 126.5, 124.8, 123.3, 85.8, 48.6, 37.9, 29.7, 28.1, 27.4, 26.1, 25.7;
HRMS (m/z): [M]+: calcd. for C14H18NaO: 225.1255; found: 225.1206; HPLC conditions:
Column: OJH, Mobile phase: heptane : ethanol (96:4), enantiomers at 10.87 min and
12.77 min. Flow rate: 1 ml / min.
19
1-(naphthalen-1-yl)-1-phenylethanol
3-methyl-1-phenylpentan-3-ol
Colourless oil (74% yield); 1H-NMR (300 MHz, CDCl3): δ 7.34–7.18 (m,
5H), 2.69 (m, 2H), 1.79 (m, 2H), 1.58 (m, 2H), 1.25 (s, 3H), 0.97
(apparent t, J = 7.4 Hz, 3H). HPLC conditions: Column: IB, Mobile
phase: heptanes : ethanol (99.5:0.5), enantiomers at 18.100 min and 19.627 min. Flow
rate: 1 mL / min. NMR shifts are consistent with the literature.16
20
2-cyclohexyl-4-phenylbutan-2-ol
Colourless solid (75% yield); 1H-NMR (400 MHz, CDCl3): δ 7.38–7.12 (m, 5H), 2.71 (m,
13
2H), 1.95-1.61 (m, 6H), 1.40 (m, 1H), 1.26 – 0.95 (m, 9H); C NMR (101 MHz, CDCll3): δ
142.85, 128.36, 128.32, 125.66, 74.39, 47.58, 41.89, 29.81, 27.58, 26.89, 26.78, 26.73,
26.51, 23.84. HRMS (m/z): [M]+: calcd. for C16H24ONa: 255.1725;
found: 255.1718; HPLC conditions: Column: IB, Mobile phase:
heptanes : ethanol (99:1), enantiomers at 18.100 min and 19.627
min. Flow rate: 1 mL / min.
21
3-phenyl-1-(piperidin-1-yl)pentan-3-ol
22
5. Asymmetric Synthesis of α-Tocopherol precursor A (3R,7R,11R)-1-(2,5-
dimethoxy-3,4,6-trimethylphenyl)-3,7,11,15-tetramethyl hexadecan-3-ol and
(3S,7R,11R)-diastereomer
O O MeMgI O HO
L1 (1.0 eq.)
toluene,
O -78 oC
O (R,R)-L1 - SRR-(-)-product, 92% de
(S,S)-L1 - RRR-(+)-product, 90% de
(7R,11R)-1-(2,5-Dimethoxy-3,4,6-trimethylphenyl)-7,11,15-trimethylhexadecan-3-one1 was
treated with methyl magnesium bromide according to General Procedure A using (S,S)-
L1 for asymmetric Grignard synthesis. Purification by flash chromatography (cyclohexane :
ethyl acetate, 9:1) gave the product as a colourless oil (37 mg, 78% yield). The same
procedure with (R,R)-L1 gave 92% de of SRR diastereoisomer. The absolute configuration
was determined through their optical rotations, compared to the literature values.17
1
H NMR (400 MHz, CDCl3): δ 3.72 (s, 3H), 3.64 (s, 3H), 2.72 (m, 2H), 2.22 (s, 3H), 2.18 (s,
13
6H), 1.70 – 1.02 (m, 26H), 0.89 - 0.82 (m, 12H). C NMR (101 MHz, CDCl3) δ 153.09,
152.64, 132.24, 128.21, 127.92, 127.07, 72.76, 60.87, 60.05, 42.28, 41.81, 41.78, 39.34,
37.69, 37.41, 37.26, 32.81, 32.77, 27.94, 26.71, 26.69, 24.76, 24.48, 22.68, 22.59, 21.67,
21.46, 19.72, 12.84, 12.65, 11.94; α21=−1.57
(c=0.75
in
CHCl3)
for
SRR
diastereoisomer
SCF Conditions: Column: IA; Co-solvent: methanol (gradient 1% to 40%, ref. Table 1);
Column Temperature: 35 ˚C; Flow rate: 3.0 mL/min; Diastereoisomers at 2.9 min SRR and
3.2 min RRR.
Table 1. SCF Gradient Table
Flow Rate
No. Time [min] %MeOH
[ml/min]
1 Initial 3.000 1.0
2 1.0 3.000 1.0
3 5.0 3.000 40.0
4 5.1 3.000 1.0
23
reaction performed with no added ligand w/ (R,R)-ligand: SRR (major) RRR (minor)
24
Table 1. Detailed comparison of methods for asymmetric nucleophilic addition to
ketones mentioned in Scheme 1 (Main Text).
25
The main advantage of Method 1 is its high selectivity for the addition of linear Grignards
to sp2-methyl ketones (aryl-methyl, heteroaryl-methyl, alkynyl-methyl and α,β-unsaturated-
methyl), using relatively inexpensive TADDOL ligand. The method, however requires
extremely harsh conditions (-105 ˚C), long reaction times (9-11 h) and large amount of
Grignard reagent (3.0 eq.). The ligand is a tertiary alcohol itself therefore it is difficult to
remove from the reaction mixture and the distillation of crude product is only possible for
relatively small molecules. The scope of the reaction in Grignard reagent is limited to linear
Grignards only (ethyl, n-butyl etc.) and ketone scope is limited to sp2-metyl ketones.
Method 3 belongs to the same group as Method 1 – the direct organomagnesium addition
to ketones, mediated by a stoichiometric amount easily accessible chiral ligand, but unlike
Method 1 it does not require such extreme conditions (temperature) and the reaction is
complete in 30 min. The ligand is tunable and can be easily prepared, removed from the
reaction mixture and recycled. The other advantage is that the method has a much
broader scope than Methods 1 and 2 – both (1) in terms of Grignard reagents: it works for
methyl and ethyl Grignard (ee>90%) – linear, for branched, cyclic and naphthyl (ee>75%);
(2) in terms of a ketone – it give high selectivities and yields for both for aryl-alkyl ketones
(ee>90%) and alkyl-alkyl ketones (ee>90%). Its application to α-tocopherol precursor
synthesis gave the desired alcohol in 90% / 92% de (depending on the sense of
stereochemistry) in 10 steps.
26
7. Mechanistic considerations
Figure 2. Possible stereoselective complex for ligand (S,S)-L1 for the addition of
ethylmagnesium bromide to acetophenone
. Ether solvents molecules omitted for clarity.
We envisage formation of the complex by a chain of events as presented in Figure 3.
Step 1 is a simple acid-base reaction between Grignard reagent and the acidic proton of a
ligand. This reaction is exothermic – the rise of temperature for the addition of first
equivalent of Grignard is higher than for the second - and faster than 1,2-addition. No
product was formed when 1.0 eq. of Grignard was used. As a result, the complex A is
formed (Step 2), when magnesium atom is complexed by 3 heteroatoms, occupying 3 out
of 4 sections of its coordination sphere, creating a “chiral pocket” in a 4th quarter. Following
Ashby,26 we assume formation of a dimeric species, bridged by 2 halogen atoms. The free
space around magnesiums is assumed to be occupied by ether molecules. Our
hypothesis, which requires further investigation, states that the complex formed between
an ether molecule and the ligated magnesium in a “chiral pocket” is of a higher energy that
the complex formed with an ether molecule of the “free magnesium”.
27
Figure 3. Mechanistic hypothesis for the asymmetric synthesis of tertiary alcohols using
tridentate ligands, developed in the course of this project.
Also following Ashby (in the absence of evidence to the contrary), we next assume
displacement of the “less bound” ether molecule by a ketone and the formation of complex
B is the next, slow and rate determining step. This hypothesis is supported by the ether
studies (Table 2, the paper) presented in Figure 4.
Results obtained with different ethers indicate “all or nothing” type of a situation, when
bulky and less Lewis basic ether provides “ON” mode of enantioselectivity, while THF – a
small ether and strong Lewis base produces a racemate (“OFF” mode). The above
phenomenon can be explained by the strong “inhibition” of the active site on ligated
magnesium atom by THF. This hypothesis is supported by the observation, that the
enantioselectivity is restored, when 2,5-dimethyl THF is used instead, which is
considerably more bulky and produces a complex of a higher energy with a ligated
magnesium atom, therefore it is easier to displace by a ketone.
We assume that the stereoselection occurs because the ketone adopts one of two
possible fixed positions in the product of Step 3 with a fixed orientation of its groups. We
can speculate that the stereoselective complex is formed in Step 3, such that all elements
rapidly adopt the geometrically preferential arrangement in a pseudo-chair conformation in
a six-membered ring (Figure 2) and the carbanion is transferred to the pre-oriented ketone
to yield complex C (Step 5), which is hydrolysed in the workup to chiral tertiary alcohol.
The experimental data presented in Table 2 in the paper is consistent with the above
model. We can see that for example, the (S,S)-ligand influences (R) sense of
stereoselectivity for the addition of ethyl magnesium bromide to acetophenone by addition
of carbanion “from the back” (see Figure 5). We have also observed that the mirror image
of the ligand produces the opposite sense of stereochemistry of the product, as expected
29
The above observations strongly support the involvement of a single stereoselective
mechanism. Further mechanistic investigations will be reported in due course.
8. References
1 B. Bieszczad, D. G. Gilheany, submitted for publication.
2
H. J. Schanz, M. Linseis, D. G, Gilheany, Tetrahedron: Asymmetry 2003, 14, 2763–2769.
3 Y. Zhu, J. P. Malerich, R. Viresh, Angew. Chem. Int. Ed. 2010, 49, 153–156.
4 A. M. Lopez-Periago, C. A. Garcia-Gonzalez, C. Domingo, Chem. Comm. 2010, 46, 4315 – 4317.
5 D. W. Lee, H. J. Ha, W. K. Lee, Synth. Commun. 2007, 37, 737–742.
6 G. Labourdette, D. J. Lee, B. O. Patrick, M. E. Ezhova, P. Mehrkhodavandi, Organometallics 2009, 28,
1309–1319.
7 H. Christensen, Synth. Comm. 1975, 1, 61-78
8 Yields were measured as isolated yields and 1H NMR yields with ligand acting as an internal standard
9 S.-J. Jeon, J. Li, C. Garcia, L. K. LaRochelle, P. J. Walsh, J. Org. Chem. 2005, 70, 448-455.
10 H. Zong, H. Huang, J. Liu, G. Bian, L. Song, J. Org. Chem. 2012, 77, 4645-4652.
11 M. Yus, D. J. Ramon, O. Prieto, Tetrahedron: Asymmetry 2003, 14, 1103-1114.
12 C. A. Musser, Jr. H. Richey, J. Org. Chem. 2000, 65, 7750–7756.
13 H. J. Hamann, J. A. Liebscher, J. Org. Chem. 2000, 65, 1873-1876.
14 D. Oezdemirhan, S. Sezer, Y. Soenmez, Tetrahedron: Asymmetry 2008, 19, 2717-2720.
15 C. A. Chen, K. H. Wu, H. M. Gau, Angew. Chem. Int. Ed. 2007, 46, 5373-5376.
16 A. G. Sakhabutdinov, A. G. Usmanova, A. G. Proidakov, B. A. Bazhenov, F. K. Shmidt, Zhurnal
Organicheskoi Khimii 1988, 8, 1691-1696.
17 S. Takano, T. Sugihara, K. Ogasawara, Synlett 1990, 8, 451.
18 B. Weber, D. Seebach, Tetrahedron 1994, 50, 6117-6128,
19 A. V. R. Madduri, S. R. Harutyunyan, A. J. Minnaard, Angew. Chem. Int. Ed. 2012, 51, 3164.
20 However, the reaction time for Grignard addition to α-methyl substituted α,β-unsaturated ketones was
quoted as 5-10 h and for the addition of isobutyl Grignard to Ar-SiPh2Me ketone lasted 2h.
21 All prices from Sigma-Aldrich, 23 November 2016.
22 J. Rong, R. Oost, A. Desmarchelier, A. J. Minnaard, S. R. Harutyunyan, Angew. Chem. Int. Ed. 2014,
53, 1.
23 A. V. R. Madduri, A. J. Minnaard, S. E. Harutyunyan, S. E., Chem. Comm. 2012, 48, 1478–1480.
24 For the specific case of aryl-SiPh2Me ketones, good results (ee>80%) were also obtained for linear
Grignards.
25 Z. Wu, S. R. Harutyunyan, A. J. Minnaard, Chem. Eur. J. 2014, 20, 14250
26 E. C. Ashby, J. Laemmle, H. M. Neumann, Acc. Chem. Res. 1974, 7, 272.
30